Table 5 Findings of CFR in some diseases associated to coronary microvascular dysfunction and in healthy controls [36]
Clinical setting | CFR |
|---|---|
Hypertrophic cardiomyopathy | 2.21 ± 0.2 |
Dilated cardiomyopathy | 1.9 ± 0.2 |
Syndrome X | 2.27 ± 0,3 |
Control group | 3.3 ± 0.3 |